Get the Stockscreener App
94.80
0.06%
-0.06
Merus N V stock is traded at $94.80, with a volume of 360.14K.
It is down -0.06% in the last 24 hours and up +0.54% over the past month.
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
See More
Previous Close:
$94.86
Open:
$94.82
24h Volume:
360.14K
Relative Volume:
0.17
Market Cap:
$7.17B
Revenue:
$35.93M
Net Income/Loss:
$-244.56M
P/E Ratio:
-24.00
EPS:
-3.95
Net Cash Flow:
$-157.31M
1W Performance:
+0.21%
1M Performance:
+0.54%
6M Performance:
+114.53%
1Y Performance:
+88.47%
1-Day Range:
$94.75
$94.90
1-Week Range:
$94.58
$95.30
52-Week Range:
$33.19
$95.30
Merus N V Stock (MRUS) Company Profile
Name
Merus N V
Sector
Industry
Phone
31 030 253 8800
Address
YALELAAN 62, 3584 CM UTRECHT
Compare MRUS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRUS
Merus N V
|
94.81 | 7.19B | 35.93M | -244.56M | -157.31M | -3.95 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.69 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.80 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.61 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.11 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.82 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Merus N V Stock (MRUS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-17-25 | Initiated | Barclays | Overweight |
| Aug-25-25 | Initiated | Alliance Global Partners | Buy |
| Feb-13-25 | Initiated | Piper Sandler | Overweight |
| Feb-07-25 | Initiated | Wells Fargo | Overweight |
| Nov-21-24 | Initiated | Goldman | Buy |
| Oct-24-24 | Initiated | UBS | Buy |
| Mar-28-24 | Initiated | Truist | Buy |
| Mar-04-24 | Reiterated | Needham | Buy |
| Nov-02-23 | Initiated | Canaccord Genuity | Buy |
| Aug-21-23 | Initiated | TD Cowen | Outperform |
| Aug-02-22 | Initiated | Stifel | Buy |
| Feb-11-22 | Initiated | BMO Capital Markets | Outperform |
| Feb-10-22 | Initiated | Needham | Buy |
| Nov-17-21 | Resumed | Guggenheim | Buy |
| Jun-07-21 | Upgrade | Citigroup | Neutral → Buy |
| Apr-08-21 | Initiated | William Blair | Outperform |
| Mar-16-21 | Initiated | SVB Leerink | Outperform |
| Jun-26-20 | Initiated | H.C. Wainwright | Buy |
| May-27-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-20-19 | Resumed | Guggenheim | Buy |
| Jun-28-19 | Initiated | ROTH Capital | Buy |
| Apr-12-19 | Resumed | Guggenheim | Buy |
| Apr-03-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Mar-27-19 | Initiated | Berenberg | Buy |
| Jan-02-18 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-15-17 | Initiated | RBC Capital Mkts | Outperform |
| Mar-21-17 | Downgrade | Citigroup | Buy → Neutral |
| Dec-22-16 | Upgrade | Citigroup | Neutral → Buy |
| Nov-07-16 | Downgrade | Citigroup | Buy → Neutral |
| Jun-13-16 | Initiated | Citigroup | Buy |
| Jun-13-16 | Initiated | Guggenheim | Buy |
| Jun-13-16 | Initiated | Wedbush | Outperform |
View All
Merus N V Stock (MRUS) Latest News
Will Merus N.V. (2GH) stock keep high P E multiplesJuly 2025 Decliners & High Conviction Buy Zone Picks - newser.com
Is Merus N.V. stock a buy for dividend growth2025 Sector Review & Growth Focused Stock Pick Reports - newser.com
Can Merus N.V. stock double in next 5 yearsQuarterly Performance Summary & Community Trade Idea Sharing Platform - newser.com
Market reaction to Merus N.V.’s recent newsEarnings Miss & Advanced Swing Trade Entry Alerts - newser.com
Merus N.V. stock volume spike explained2025 Volatility Report & Community Shared Stock Ideas - newser.com
Can Merus N.V. (2GH) stock test all time highsMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
Will Merus N.V. stock outperform Nasdaq indexJuly 2025 PostEarnings & Detailed Earnings Play Strategies - newser.com
Is Merus N.V. stock a buy before product launchesRecession Risk & Low Risk High Reward Ideas - newser.com
Will Merus N.V. stock deliver better than expected guidanceEarnings Risk Report & AI Powered Trade Plan Recommendations - newser.com
Key metrics from Merus N.V.’s quarterly data2025 Fundamental Recap & Accurate Entry/Exit Alerts - newser.com
Is Merus N.V. stock resilient to inflationJuly 2025 Catalysts & Smart Investment Allocation Insights - newser.com
Why Merus N.V. (2GH) stock could outperform next year2025 Short Interest & Reliable Momentum Entry Alerts - newser.com
Merus NV’s Financial Stability at Risk Due to Unproven ADClonics Technology and Supply Chain Vulnerabilities - TipRanks
Can Merus N.V. (2GH) stock sustain revenue momentumJuly 2025 Trade Ideas & Proven Capital Preservation Methods - newser.com
Merus NV Faces Uncertainty and Risks Amid Genmab A/S Transaction Delays - TipRanks
Merus (MRUS) Forecasts 58.4% Revenue Growth, Ongoing Losses Challenge Bullish Narratives - simplywall.st
Is Merus N.V. stock reversal real or fake2025 Technical Overview & High Accuracy Swing Entry Alerts - newser.com
Merus N.V. $MRUS Shares Sold by Moody Aldrich Partners LLC - MarketBeat
Will Merus N.V. stock sustain high P E ratiosWeekly Profit Analysis & Daily Chart Pattern Signal Reports - newser.com
What risks investors should watch in Merus N.V. stock2025 Trade Ideas & Real-Time Stock Movement Alerts - newser.com
Merus NV reports results for the quarter ended September 30Earnings Summary - TradingView
Merus stock maintains Market Perform rating at BMO Capital By Investing.com - Investing.com South Africa
Merus stock maintains Market Perform rating at BMO Capital - Investing.com
Genmab, Merus file US antitrust paperwork - MLex
Merus (NASDAQ:MRUS) Sets New 52-Week HighTime to Buy? - MarketBeat
Assessing Merus (MRUS) Valuation After This Year’s 120% Share Price Rally - simplywall.st
What market sentiment indicators show for Merus N.V. (2GH) stockPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com
How big funds are accumulating Merus N.V. (2GH) stockDollar Strength & Growth Oriented Trade Recommendations - newser.com
Why Merus N.V. stock remains on buy listsWeekly Gains Report & Free Daily Entry Point Trade Alerts - newser.com
Why Merus N.V. stock appeals to dividend seekers2025 Volatility Report & Community Shared Stock Ideas - newser.com
Merus NV Hits New 52-Week High of $95.30, Up 77.78% - Markets Mojo
Merus N V Stock (MRUS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Merus N V Stock (MRUS) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Silverman Peter B. | COO & GC |
Jul 17 '25 |
Sale |
60.00 |
25,000 |
1,500,000 |
0 |
0.29%
0.16%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):